Latest Earnings Results: Q2 '26
Estimated EPS
-$0.09
Reported EPS
-$0.08
Surprise
+11.11%
Estimated Rev
$6.51M
Reported Rev
$7.27M
Surprise
+11.76%
• Reported GAAP EPS of -$0.08 up 33.33% YoY • Reported revenue of $7.27M down -14.53% YoY • MaxCyte expects full year 2026 revenue of $30 million to $32 million, consisting of $25 million to $27 million in core revenue and approximately $5 million in SPL Program-related revenue.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.08 | -- | -- | N/A |
Q2 '26 | -$0.09 | -$0.08 | 11.11% | BEAT |
Q1 '26 | -$0.08 | -$0.04 | 47.23% | BEAT |
Q4 '25 | -$0.08 | -$0.09 | -17.96% | MISSED |
Q3 '25 | -$0.11 | -$0.12 | -6.29% | MISSED |